Drug Discovery World

MARCH 2, 2023

AVA6000 is a pre|CISION tumour-targeted form of the established chemotherapy doxorubicin; designed to limit cell penetration of the drug — and therefore its cell killing effect — until it is specifically activated by fibroblast activation protein α (FAP), which is in high concentration in many solid tumours compared with healthy tissues.

Trials 52

Trials Development Genetic Analysis Drugs 52

Drug Discovery World

FEBRUARY 28, 2023

As we turn our focus to new potential applications and disease areas for the platform, scientists and companies must consider the potential life-saving impact on rare, inherited diseases, says Archana Gupta , PhD, staff scientist in genetic sciences at Thermo Fisher Scientific.

Genetics 52

Genetics Genetic Analysis Vaccination Vaccine 52

pharmaphorum

APRIL 5, 2022

The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking at changes to 52 proteins when they are exposed to a panel of targeted anticancer drugs. The post AI test could predict best cancer therapies for patients appeared first on.

Protein 67

Protein Genetic Analysis Genome Genomics 67

Drug Discovery World

APRIL 21, 2023

Managing all of these elements using iterative design and prototyping can play a key role in successful project delivery, and marrying technologies with biochemical or cellular assays has the potential to bring disruptive change across fields as diverse as personalised medicine, diagnostics and drug screening.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

Drug Discovery World

JUNE 14, 2023

The spokesperson continued by stating that NHSBT supports many steps of the stem cell transplantation and advanced therapies supply chains, including donor identification and tissue typing services, cell collection, processing, freezing and storage, through to cell expansion and genetic modification.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52